Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.
about
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in TumorsThe Place of FDG PET/CT in Renal Cell Carcinoma: Value and LimitationsDevelopment of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary reportSentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease courseMolecular imaging of the kidneysMeta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.Recent developments in kidney cancerClinical effectiveness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in management of renal cell carcinoma: a single institution experience.Positron emission tomography in uro-oncology.Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imagingFDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.Positron emission tomography: clinical applications in oncology. Part 2.Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma.FDG PET or PET/CT in evaluation of renal angiomyolipomaMalignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature.Update on radiological imaging of renal cell carcinoma.Imaging in genitourinary cancer from the urologists' perspective.Recurrent renal cell carcinoma manifesting as a large intrathoracic fibrotic mass: A case report.Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma.Evaluation of the biodistribution of 11C-methionine in children and young adults.Positron emission tomography/computed tomography imaging features of renal cell carcinoma and pulmonary metastases in a dog.The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.Imaging of renal cell carcinoma: state of the art and recent advances.The role of functional imaging in the era of targeted therapy of renal cell carcinoma.Is The Value of FDG PET/CT In Evaluating Renal Metastasis Underestimated? A Case Report And Review of The Literature.Lymphatic drainage in renal cell carcinoma: back to the basics.18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.Synchronous Oligometastatic Non-Small Cell Lung Cancer and Isolated Renal Cell Carcinoma: A Case Report and Literature ReviewSpinal metastases: multimodality imaging in diagnosis and stereotactic body radiation therapy planning.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Imaging features of solid renal masses.A rare site of hyoid bone metastasis in patients with renal cell carcinoma on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan.Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor.
P2860
Q26996477-6EA1D0CB-4CF4-4291-A8BF-D7EC6C3B5DB5Q28070239-CCBD4CB9-EF99-42D6-81E9-E96BFEF0387FQ33301860-A20F8720-A786-43FF-B977-1ED960C66D75Q33639383-AD556079-15A7-4872-B74F-FAD09DC84352Q33762689-499CF5A9-5495-4F1A-A448-8B81FA72D26BQ34212537-6450D744-44A2-4341-8ED0-DA5C99A6E44BQ34253776-D4A38001-0E6F-49DC-8EDC-E0AEDB6929E4Q34408777-AFF4BC52-FB9D-4070-B757-C0C6FBE4BBD1Q34644707-3FDC8565-653E-4C63-A267-F9CC1FD02279Q35042440-BF589127-1CE7-45F5-A781-7E6971854A49Q35109393-74ABC022-AB1B-4979-BB82-8CAE133FA2CDQ35172954-779B7910-1DBE-4C00-9021-E1CCFE2B7FB9Q35675742-F82256BF-8820-4C10-880D-B2A3E2B99740Q35917780-A0C4228E-1EBC-476A-9E80-9B430E2B4EF8Q36023626-0AAB0A87-3125-4594-8E48-9E6E60EA305BQ36448703-91CC1E08-CB41-4C69-8588-61F45017745CQ36462104-E4BAA1FF-AEC4-4FD2-A96B-74F17CD28BF9Q36567385-8DFE1717-7509-4CDD-8E72-8DE8CB1E22F5Q36662636-E16333E6-DBE1-4215-B273-9D9C20F3B141Q36710899-28D8567C-B8C2-4A1D-8D4C-C313A90C1943Q36794762-D5039C83-1774-45FA-AE68-2C51A8C717B2Q36834536-F9ECB93A-8559-4D91-9562-92866D3D737DQ36954538-ABF8CB7B-B0EB-4587-BB81-FA702D83AD04Q36961767-BC846B2C-1E8F-42EB-AE96-C410D53AC79BQ37025955-D8544F27-7665-4679-9AFD-A1F4669217EAQ37068011-CAD448FC-EBB1-422A-A378-DF03B7E22E4DQ37584750-9F7F29F0-00AC-4E27-A1A0-CB5F0CE53D30Q37711287-6E6B3790-09BB-4094-A639-D4F1BC9CC806Q37725130-7F73A157-B2C5-4969-857D-17B294394730Q37819763-E00587F6-1CBA-44BA-B37E-918E0D995E6BQ38099238-3A5471E9-97BE-4475-8D58-2B3FA775280DQ38177815-7F751EB4-5000-4685-8834-14E315FF6EA0Q38212891-93222549-C2CC-4117-8E14-1482F3C2D16BQ38411777-8322CEB5-CEAA-44B0-8930-6675EB12411CQ38654684-B24D075C-E84D-4D6F-A6F1-BBF6D4CDACE2Q38831525-F196A5A1-F8AF-475E-AD24-6F3DAF1951B8Q39307896-B2B8204F-5DD7-4A7D-9FBF-A3CE17B0D209Q39357543-14BD908F-CEAA-47ED-9C84-69CD7380E55BQ41219787-32DC8596-DBA6-4622-9FD6-3153F9F803FEQ41852917-D5CFBC5D-2416-4D4A-B32E-53D5234C6588
P2860
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@ast
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@en
type
label
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@ast
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@en
prefLabel
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@ast
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@en
P2093
P1476
Clinical use of fluorodeoxyglu ...... ction of renal cell carcinoma.
@en
P2093
Chris M Teigland
David E Kang
Howell C Sasser
James H Zuger
Richard L White
P304
P356
10.1097/01.JU.0000120241.50061.E4
P407
P577
2004-05-01T00:00:00Z